<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医脉通血液科 | wechat-feeds</title><link>http://MjM5OTA3MzIwMA.favicon.privacyhide.com/favicon.ico</link><description>医脉通血液科主要提供国内外血液前沿资讯，热门血液指南，国内外血液会议报道，精彩血液病例！ “饕餮”血液，尽在医脉通血液科！</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 07 May 2021 19:22:07 +0800</pubDate><image><url>http://MjM5OTA3MzIwMA.favicon.privacyhide.com/favicon.ico</url><title>医脉通血液科 | wechat-feeds</title><link>http://MjM5OTA3MzIwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>王建祥教授：国内新获批的DRd/DVd联合疗法助力实现首次复发MM“深度缓解、更长生存”的治疗目标</title><link>https://mp.weixin.qq.com/s/0V1nyuMGGDpbhJt6WfYarw</link><description></description><content:encoded><![CDATA[王建祥教授：国内新获批的DRd/DVd联合疗法助力实现首次复发MM“深度缓解、更长生存”的治疗目标]]></content:encoded><pubDate>Fri, 07 May 2021 17:28:22 +0800</pubDate></item><item><title>维布妥昔单抗在儿童初诊cHL中大有可为</title><link>https://mp.weixin.qq.com/s/Vp7fJUi9iRfRe-nFEQ7eRQ</link><description></description><content:encoded><![CDATA[维布妥昔单抗在儿童初诊cHL中大有可为]]></content:encoded><pubDate>Fri, 07 May 2021 17:28:22 +0800</pubDate></item><item><title>ROCK2抑制剂Belumosudil有望为难治cGVHD患者带来新希望</title><link>https://mp.weixin.qq.com/s/UUSVwcDe9RkT_i4RLqSKbw</link><description></description><content:encoded><![CDATA[ROCK2抑制剂Belumosudil有望为难治cGVHD患者带来新希望]]></content:encoded><pubDate>Fri, 07 May 2021 17:28:22 +0800</pubDate></item><item><title>缓解率100%！创新通用型CAR-T细胞疗法，有望拯救致命白血病</title><link>https://mp.weixin.qq.com/s/EWDCqp7j3EPTuTsb9YfqjA</link><description></description><content:encoded><![CDATA[缓解率100%！创新通用型CAR-T细胞疗法，有望拯救致命白血病]]></content:encoded><pubDate>Fri, 07 May 2021 17:28:22 +0800</pubDate></item><item><title>【淋巴瘤微课】中国慢性淋巴细胞白血病特征性遗传学异常</title><link>https://mp.weixin.qq.com/s/G4AAfO_WntFS3k5jrxqFkQ</link><description></description><content:encoded><![CDATA[【淋巴瘤微课】中国慢性淋巴细胞白血病特征性遗传学异常]]></content:encoded><pubDate>Thu, 06 May 2021 17:28:02 +0800</pubDate></item><item><title>如何降低儿童HCT后肺损伤的发生率？</title><link>https://mp.weixin.qq.com/s/ftdieodBrx5SdUAHX15GZA</link><description></description><content:encoded><![CDATA[如何降低儿童HCT后肺损伤的发生率？]]></content:encoded><pubDate>Thu, 06 May 2021 17:28:02 +0800</pubDate></item><item><title>临研人必读 | 软件演示：教会大家操作iBOIN设计</title><link>https://mp.weixin.qq.com/s/nWWjKbt1rDWycoA3BWdHjA</link><description></description><content:encoded><![CDATA[临研人必读 | 软件演示：教会大家操作iBOIN设计]]></content:encoded><pubDate>Thu, 06 May 2021 17:28:02 +0800</pubDate></item><item><title>BOC/BOA 2021 China会议日程框架</title><link>https://mp.weixin.qq.com/s/PUVXKU9v_4yHonPnT8tAww</link><description></description><content:encoded><![CDATA[BOC/BOA 2021 China会议日程框架]]></content:encoded><pubDate>Thu, 06 May 2021 17:28:02 +0800</pubDate></item><item><title>如何判断成人高危Ph-ALL是否需要异基因造血干细胞移植？</title><link>https://mp.weixin.qq.com/s/xEu12ywn_Xd3uUQfr0hZFA</link><description></description><content:encoded><![CDATA[如何判断成人高危Ph-ALL是否需要异基因造血干细胞移植？]]></content:encoded><pubDate>Tue, 04 May 2021 13:03:26 +0800</pubDate></item><item><title>医院14个科室招聘，男性优先！女性就业处于濒危境地……</title><link>https://mp.weixin.qq.com/s/arG3qOaD51dK5EvuuOoQkA</link><description></description><content:encoded><![CDATA[医院14个科室招聘，男性优先！女性就业处于濒危境地……]]></content:encoded><pubDate>Tue, 04 May 2021 13:03:26 +0800</pubDate></item><item><title>Abatacept可有效预防急性移植物抗宿主病</title><link>https://mp.weixin.qq.com/s/JdVFmwJigYj1TW44Iz988Q</link><description></description><content:encoded><![CDATA[Abatacept可有效预防急性移植物抗宿主病]]></content:encoded><pubDate>Tue, 04 May 2021 13:01:40 +0800</pubDate></item><item><title>倒计时2天！“E问答”麦粒大派送</title><link>https://mp.weixin.qq.com/s/MB7SoKUaOKcIcrFfPhFn8g</link><description></description><content:encoded><![CDATA[倒计时2天！“E问答”麦粒大派送]]></content:encoded><pubDate>Tue, 04 May 2021 13:01:40 +0800</pubDate></item><item><title>如何识别皮肤CD30 阳性T细胞淋巴组织增生性疾病？</title><link>https://mp.weixin.qq.com/s/Fza6qvUzgmhZ-6lnQ-752Q</link><description></description><content:encoded><![CDATA[如何识别皮肤CD30 阳性T细胞淋巴组织增生性疾病？]]></content:encoded><pubDate>Sun, 02 May 2021 12:41:22 +0800</pubDate></item><item><title>没用过这款文献翻译管理神器，枉费苦读十年书！</title><link>https://mp.weixin.qq.com/s/HI2GuygFuuJuqap4_FDpZg</link><description></description><content:encoded><![CDATA[没用过这款文献翻译管理神器，枉费苦读十年书！]]></content:encoded><pubDate>Sun, 02 May 2021 12:41:22 +0800</pubDate></item><item><title>2021版CSCO儿童及青少年淋巴瘤指南更新要点解读</title><link>https://mp.weixin.qq.com/s/U2c7Kwh3liqXQOuV0tjEqw</link><description></description><content:encoded><![CDATA[2021版CSCO儿童及青少年淋巴瘤指南更新要点解读]]></content:encoded><pubDate>Sat, 01 May 2021 16:07:25 +0800</pubDate></item><item><title>显微镜下练就的火眼金睛——一例极早期白血病现形记</title><link>https://mp.weixin.qq.com/s/lL0pOB9MpeC7vvS8pJYVCg</link><description></description><content:encoded><![CDATA[显微镜下练就的火眼金睛——一例极早期白血病现形记]]></content:encoded><pubDate>Sat, 01 May 2021 16:07:25 +0800</pubDate></item><item><title>2021版CSCO淋巴瘤18F-FDG PET/CT指南解读</title><link>https://mp.weixin.qq.com/s/hnDrCZdeXJ24Yje1yjetig</link><description></description><content:encoded><![CDATA[2021版CSCO淋巴瘤18F-FDG PET/CT指南解读]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:54:31 +0800</pubDate></item><item><title>KMT2A阳性AL移植后MRD监测与免疫干预治疗</title><link>https://mp.weixin.qq.com/s/2k2UeRCS826HVACcZ6m74g</link><description></description><content:encoded><![CDATA[KMT2A阳性AL移植后MRD监测与免疫干预治疗]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:54:31 +0800</pubDate></item><item><title>大咖访谈丨淋巴瘤专科建设开启精细化诊疗未来</title><link>https://mp.weixin.qq.com/s/iT-MvF1EgqPU0_gBEcK4hw</link><description></description><content:encoded><![CDATA[大咖访谈丨淋巴瘤专科建设开启精细化诊疗未来]]></content:encoded><pubDate>Fri, 30 Apr 2021 15:15:51 +0800</pubDate></item><item><title>武田维葡瑞®（注射用维拉苷酶α）获批进入中国，为中国戈谢病患者带来生命新希望</title><link>https://mp.weixin.qq.com/s/t4RpF0Oz0c6qrqHmNnUK9w</link><description></description><content:encoded><![CDATA[武田维葡瑞®（注射用维拉苷酶α）获批进入中国，为中国戈谢病患者带来生命新希望]]></content:encoded><pubDate>Fri, 30 Apr 2021 15:15:51 +0800</pubDate></item></channel></rss>